X T L Biopharmaceuticals Ltd
TASE:XTLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X
|
X T L Biopharmaceuticals Ltd
TASE:XTLB
|
IL |
|
Intellipharmaceutics International Inc
TSX:IPCI
|
CA |
|
J
|
Jungdawn Co Ltd
KOSDAQ:208140
|
KR |
|
Platinum Group Metals Ltd
TSX:PTM
|
CA |
|
AYRO Inc
NASDAQ:AYRO
|
US |
|
Intelligent Monitoring Group Ltd
ASX:IMB
|
AU |
|
Gold Springs Resource Corp
TSX:GRC
|
CA |
|
Gambling.com Group Ltd
F:6WH
|
JE |
|
Wakou Shokuhin Co Ltd
TSE:2813
|
JP |
|
V
|
Veeva Systems Inc
F:VEE
|
US |
|
Jindal Poly Films Ltd
NSE:JINDALPOLY
|
IN |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
Shareholder Yield
Current shareholder yield for XTLB is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
XTLB Price
X T L Biopharmaceuticals Ltd
| Average Annual Return | -4.66% |
| Standard Deviation of Annual Returns | 67.15% |
| Max Drawdown | -90% |
| Market Capitalization | 18m ILS |
| Shares Outstanding | 9 462 400 |
| Percentage of Shares Shorted |
N/A
|
